530 related articles for article (PubMed ID: 33597956)
21. Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19.
Balta MG; Papathanasiou E; Christopoulos PF
Front Immunol; 2021; 12():632238. PubMed ID: 33717168
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
23. Consideration of immunomodulatory actions of morphine in COVID-19 - Short report.
Hudzik B; Nowak J; Zubelewicz-Szkodzinska B
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13062-13064. PubMed ID: 33378059
[TBL] [Abstract][Full Text] [Related]
24. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.
Lu L; Zhang H; Dauphars DJ; He YW
Trends Immunol; 2021 Jan; 42(1):3-5. PubMed ID: 33214057
[TBL] [Abstract][Full Text] [Related]
25. The Fight Against Severe COVID-19: Can Parasitic Worms Contribute?
Cai P; Mu Y; McManus DP
Front Immunol; 2022; 13():849465. PubMed ID: 35222441
[No Abstract] [Full Text] [Related]
26. Tackling the COVID-19 "cytokine storm" with microRNA mimics directly targeting the 3'UTR of pro-inflammatory mRNAs.
Gasparello J; Finotti A; Gambari R
Med Hypotheses; 2021 Jan; 146():110415. PubMed ID: 33422363
[TBL] [Abstract][Full Text] [Related]
27. Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm.
Panoskaltsis N; McCarthy NE; Stagg AJ; Mummery CJ; Husni M; Arebi N; Greenstein D; Price CL; Al-Hassi HO; Koutinas M; Mantalaris A; Knight SC
Cancer Immunol Immunother; 2021 Apr; 70(4):1127-1142. PubMed ID: 33033851
[TBL] [Abstract][Full Text] [Related]
28. The cytokine storm of COVID-19: a spotlight on prevention and protection.
Pearce L; Davidson SM; Yellon DM
Expert Opin Ther Targets; 2020 Aug; 24(8):723-730. PubMed ID: 32594778
[TBL] [Abstract][Full Text] [Related]
29. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.
Moreno Fernández-Ayala DJ; Navas P; López-Lluch G
Exp Gerontol; 2020 Dec; 142():111147. PubMed ID: 33171276
[TBL] [Abstract][Full Text] [Related]
30. Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19.
Dalamaga M; Karampela I; Mantzoros CS
Metabolism; 2020 Aug; 109():154282. PubMed ID: 32497535
[TBL] [Abstract][Full Text] [Related]
31. The Novel Coronavirus and Inflammation.
George JA; Mayne ES
Adv Exp Med Biol; 2021; 1321():127-138. PubMed ID: 33656719
[TBL] [Abstract][Full Text] [Related]
32. What Is a Cytokine Storm and Should It Matter to Me?
Simkin J; Strange T; Leblanc N; Rivera JC
J Am Acad Orthop Surg; 2021 Apr; 29(7):297-299. PubMed ID: 33443384
[TBL] [Abstract][Full Text] [Related]
33. Immunological basis of virus-host interaction in COVID-19.
La Torre F; Leonardi L; Giardino G; Volpi S; Federici S; Soresina A; Cancrini C; Lougaris V; Castagnoli R; Corrente S; Cardinale F;
Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):75-78. PubMed ID: 33236427
[TBL] [Abstract][Full Text] [Related]
34. Illegitimate and Repeated Genomic Integration of Cell-Free Chromatin in the Aetiology of Somatic Mosaicism, Ageing, Chronic Diseases and Cancer.
Raghuram GV; Chaudhary S; Johari S; Mittra I
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31142004
[TBL] [Abstract][Full Text] [Related]
35. Cytokine storm and the prospects for immunotherapy with COVID-19.
Calabrese LH
Cleve Clin J Med; 2020 Jun; 87(7):389-393. PubMed ID: 32393592
[TBL] [Abstract][Full Text] [Related]
36. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
37. Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India.
Gokhale Y; Mehta R; Kulkarni U; Karnik N; Gokhale S; Sundar U; Chavan S; Kor A; Thakur S; Trivedi T; Kumar N; Baveja S; Wadal A; Kolte S; Deolankar A; Pednekar S; Kalekar L; Padiyar R; Londhe C; Darole P; Pol S; Gokhe SB; Padwal N; Pandey D; Yadav D; Joshi A; Badgujar H; Trivedi M; Shah P; Bhavsar P
BMC Infect Dis; 2021 Mar; 21(1):241. PubMed ID: 33673818
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps.
Borges L; Pithon-Curi TC; Curi R; Hatanaka E
Mediators Inflamm; 2020; 2020():8829674. PubMed ID: 33343232
[TBL] [Abstract][Full Text] [Related]
39. COVID-19 and ROS Storm: What is the Forecast for Hypertension.
de Oliveira AA; Priviero F; Lima VV; Webb RC; Nunes KP
Am J Hypertens; 2021 Aug; 34(8):779-782. PubMed ID: 34431501
[No Abstract] [Full Text] [Related]
40. Mechanisms by Which SARS-CoV-2 Invades and Damages the Central Nervous System: Apart from the Immune Response and Inflammatory Storm, What Else Do We Know?
Sun Z; Shi C; Jin L
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
